Pathologic reactions in the CNS

Published on 19/03/2015 by admin

Filed under Pathology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 5 (1 votes)

This article have been viewed 4755 times

1

Pathologic reactions in the CNS

PATHOLOGIC RESPONSES IN NEURONS

NORMAL NEURONAL CYTOLOGY AND STAINING

The cytologic appearance of neurons varies depending upon their location. In general, neurons have moderate to abundant cytoplasm and a relatively large round nucleus with a prominent nucleolus. Projecting from the neuronal cell body are branching dendrites and a single axon. A range of tinctorial and immunohistochemical staining techniques are used for demonstrating neurons and their processes (Table 1.1).

Table 1.1

Histologic demonstration of neurons: techniques and comments concerning their applications

Conventional staining

Hematoxylin and eosin

 Good for assessing general cytoarchitecture

Nissl stain (e.g. cresyl fast violet)

 Good for assessing general cytoarchitecture. Allows estimation of cell density in thick sections; may be combined with stains for myelin (e.g. Luxol fast blue).

Axon silver impregnation techniques

 Good for demonstration of axons and some neuronal inclusions. Used in conjunction with myelin stains to distinguish between demyelination and fiber degeneration

Golgi stain

 Allows visualization of fine detail of neuronal cell processes. A technically difficult stain to perform which depends on block impregnation

Immunohistochemistry

Neurofilament proteins

 Strongly expressed in perikaryal and axonal cytoplasm (in normal neurons, perikaryal neurofilament proteins are non-phosphorylated and axonal neurofilament proteins phosphorylated)

NeuN

 Neuron-specific nuclear protein, strongly expressed in neuronal nuclei. NeuN antibodies also show weak labeling of the neuronal cytoplasm

Neuron specific enolase

 Strongly expressed in neuronal and axonal cytoplasm

Synaptophysin

 Antibodies to synaptophysin detect neurosecretory vesicles, which are mainly located at synapses, with little staining of neuronal cell bodies

PGP9.5

 An antibody to neuron-specific ubiquitin C-terminal hydrolase, which is abundant in neurons and neuronal cell processes

Chromogranin A

 Antibodies detect dense-core neurosecretory vesicles, which are sparsely distributed within the perikaryon of some neurons and concentrated at the synapses. Moderate staining of neuronal cell bodies

Neurotransmitter-related

 Antibodies allow detection of neurotransmitter substance or enzyme involved in its biosynthesis

ABNORMALITIES OF NEURONAL MORPHOLOGY

AXONAL DEGENERATION

Axonal degeneration inevitably follows the death of the neuron of which it is a part. A severed or severely damaged axon undergoes distal degeneration without usually provoking death of the proximal part of the neuron, although this does undergo a series of structural and metabolic changes (i.e. axon reaction and chromatolysis, see below). Within days, the distal part of the axon fragments and the surrounding myelin sheath breaks up into ovoids. Over the next 3 weeks or so, the axon and myelin debris are taken up by macrophages, which infiltrate the degenerating fiber tracts. Several methods can be used to demonstrate degenerating nerve fibers in the CNS. These include specialized silver impregnation techniques and stains for degenerating myelin and for lipid (Fig. 1.1).

Marchi’s method, and oil red O or other stains for neutral lipid are particularly useful. During the first 2–3 weeks after injury when most of the products of fiber degeneration are still extracellular, their demonstration by Marchi’s method requires staining of unembedded tissue that has not fixed long in formalin. If there has been a longer period of time since the injury and much of the debris has been taken up by macrophages, Marchi’s method can be used on frozen sections and the staining is not affected by the duration of formalin fixation. Degeneration of fiber tracts can be demonstrated for several months with stains for neutral lipid, and for several years by Marchi’s method. In addition, immunohistochemistry for macrophage markers (e.g. with antibodies to CD68 and HLA class 2 antigen) is useful for detection of degenerating fiber tracts.

AXON REACTION AND CHROMATOLYSIS

Damage to the axon provokes a series of morphologic and biochemical changes in the neuronal cell body. These are collectively referred to as the axon reaction (Figs 1.2, 1.3). The changes include disruption and dispersion of Nissl bodies (chromatolysis) associated with rearrangement of the cytoskeleton and marked accumulation of intermediate filaments. The axon reaction is conspicuous in large neurons with axons that project into the peripheral nervous system and in some of the larger neurons with central projections. Chromatolysis is not visible on conventional light microscopy of small neurons or certain large neurons such as the cerebellar Purkinje cells, but changes can be demonstrated in these cells by electron microscopy and immunohistochemistry.

SWOLLEN NEURONS

Swollen or ballooned neurons are a feature both of the axon reaction and of a variety of diseases in which perikaryal changes occur independently of axonal damage (Table 1.2). Histologically, they appear as distended, weakly-staining cells with large, relatively clear nuclei (Fig. 1.4). Occasionally the cells contain small vacuoles. In conventionally processed tissues an artefactual lacuna is often present around the abnormal cell. Swollen or ballooned neurons can be demonstrated with several immunohistochemical markers (Fig. 1.5, Table 1.3).

Table 1.2

Causes of ballooning of neurons

Physiologic

 Anterior horn motor neurons, with age

Nutritional

 Pellagra (niacin deficiency): spinal, brain stem, and cortical neurons

Developmental

 Localized cortical dysplasia with cytomegaly
 Cortical dysplasia with hemimegalencephaly
 Tuberous sclerosis

Neurodegenerative

 Several types of frontotemporal lobar degeneration, including Pick’s disease and FTDP-17: neocortical and some basal neurons
 Corticobasal degeneration: neocortical and some basal neurons
 Swollen neurons can also occur in Alzheimer disease, argyrophilic grain disease, progressive supranuclear palsy and several other neurodegenerative diseases

Prion disease

 Cortical and some basal neurons

Table 1.3

Immunohistochemical profile of swollen neurons

Neurofilament protein

 Accumulation of highly phosphorylated high-molecular-weight neurofilament protein, which is normally restricted to the axon

αB-crystallin

 Accumulation of αB crystallin, which is not normally expressed by neurons

Tau protein

 Accumulation of abnormally phosphorylated tau protein by a proportion of swollen neurons in corticobasal degeneration and Pick’s disease

Ubiquitin

 Variably increased immunoreactivity for ubiquitin-protein conjugates

PGP9.5

 Variably increased immunoreactivity for this ubiquitin C-terminal hydrolase

TRANS-SYNAPTIC NEURONAL DEGENERATION AND OLIVARY HYPERTROPHY

Neurons within some nuclei in the CNS atrophy and degenerate in response to deafferentation. Examples are neurons in the lateral geniculate nucleus, which degenerate after optic nerve or tract lesions, and neurons in the pontine nuclei, which degenerate after interruption of descending frontopontine afferent fibers. Neurons in the inferior and accessory olivary nuclei undergo an unusual form of trans-synaptic degeneration after a destructive lesion (such as an infarct) of the ipsilateral central tegmental tract (Fig. 1.6). The olivary ribbon as a whole becomes thickened and neurons show marked enlargement, cytoplasmic vacuolation, and some dispersion of Nissl bodies. Olivary hypertrophy is associated with the development of palatal myoclonus in some patients.

HYPOXIC CELL CHANGE

Neurons are especially vulnerable to damage from hypoxia, which causes the following distinctive histologic changes (Fig. 1.7):

Histologic changes identical to these can be induced in neurons by hypoglycemia or by exposure to excessive amounts of excitotoxic neurotransmitters.

Cell stress proteins are expressed at an early stage of hypoxic injury and are demonstrable by immunohistochemical techniques.

Neurons in certain parts of the brain that are especially vulnerable to hypoxic damage are:

The pattern of regional susceptibility to hypoxia differs between infants and adults (see Chapters 2 and 8).

NUCLEAR INCLUSIONS

MARINESCO BODIES

These are small spherical nuclear inclusions that are brightly eosinophilic and are often seen in neurons of the adult substantia nigra (Fig. 1.9a). They may also occur in other neurons, such as the pyramidal cells of the hippocampus and neurons in the tegmentum of the brain stem. Marinesco bodies are most common in the elderly and in dementia with Lewy bodies. They have an increased prevalence in neurons containing Lewy bodies.

Ultrastructurally, Marinesco bodies are composed of filaments with the same diameter as intermediate filaments, and may be derived from the nuclear lamins. They are immunoreactive for ubiquitin, an 8 kD polypeptide involved in the degradation of many abnormal or short-lived proteins (Fig. 1.9b).

NEURONAL CYTOPLASMIC INCLUSIONS

Neuronal cytoplasmic inclusions can be divided into those composed of cytoskeletal elements, cytosolic inclusions, and membrane-bound inclusions.

CYTOSKELETAL AND FILAMENTOUS INCLUSIONS

Hirano bodies

These are brightly eosinophilic rod-shaped or elliptical cytoplasmic inclusions that may appear to overlap the edge of a neuron (Fig. 1.11). They are immunoreactive for actin, actin-associated proteins, and caspase-cleaved TDP43.

Ultrastructurally, Hirano bodies consist of a regular lattice of multiple layers of parallel 10–12 nm filaments, the filaments in one layer being transversely or diagonally oriented with respect to those in the adjacent layers.

Hirano bodies are most numerous in the CA1 field of the hippocampus. Their density in the stratum lacunosum increases until middle-age and declines gradually thereafter, except in chronic alcoholics, in whom the density may continue to increase. In the elderly, the number of Hirano bodies increases in the stratum pyramidale, and they are particularly numerous in this region in Alzheimer disease, Pick’s disease, some sub-types of Creutzfeldt–Jakob disease, and Guam parkinsonism–dementia.

OTHER FILAMENTOUS NEURONAL INCLUSIONS

There are several other types of neuronal inclusion that comprise or include elements of the cytoskeleton and usually occur in the context of specific neurodegenerative diseases (Table 1.4). These inclusions are described in more detail and illustrated in the sections concerned with the relevant diseases.

Table 1.4

Examples of inclusion bodies in specific conditions and diseases

Inclusion Association Main constituents
Lewy bodies Aging, Parkinson’s disease, dementia with Lewy bodies α-synuclein, neurofilament protein, and ubiquitin
Neurofibrillary tangles Aging, Alzheimer disease, progressive supranuclear palsy, post-encephalitic parkinsonism, Guam parkinsonism–dementia, myotonic dystrophy, subacute sclerosing panencephalitis, Niemann–Pick disease type C, other rare disorders Phosphorylated tau protein (3R, 4R), ubiquitin
Pick bodies Pick’s disease Neurofilament protein, phosphorylated tau protein (3R), ubiquitin
MND inclusions Motor neuron disease/amyotrophic lateral sclerosis TAR DNA-binding protein 43 (sporadic cases) or superoxide dismutase 1 (some familial cases) or fused-in-sarcoma protein (other familial cases) ubiquitin, p62

CYTOSOLIC INCLUSIONS

LAFORA BODIES

These are composed of polyglucosans (polymers of sulfated polysaccharides) and are similar to corpora amylacea in composition and staining characteristics (see below). They are present in large numbers in Lafora’s disease (see Chapter 7), both in the CNS and in certain peripheral tissues such as sweat glands, liver, and skeletal muscle. Lafora body formation has been linked to aberrant glycogen hyperphosphorylation. The inclusions usually have a round core that is intensely periodic acid–Schiff (PAS)-positive (Fig. 1.13). Spicules of the core may radiate outwards, into a surrounding zone of less intensely PAS-positive material.

MEMBRANE-BOUND CYTOPLASMIC INCLUSIONS

COLLOID INCLUSIONS

Colloid inclusions are round eosinophilic inclusions that usually occur in neurons in the hypoglossal nuclei (Fig. 1.15), but may be seen in other large neurons, particularly in the elderly. Electron microscopy shows that these inclusions result from dilatation of the endoplasmic reticulum by amorphous material. The importance of recognizing colloid inclusions, which do not have any clinical significance, is that they are occasionally confused with inclusions that are clinically significant such as Lewy bodies, pale bodies, and hyaline inclusions of motor neuron disease (see Chapter 27).

INCLUSIONS DERIVED FROM THE ACID VESICLE SYSTEM

The acid vesicle system consists of endosomes, lysosomes, and lysosome-derived dense bodies.

Lipofuscin (Fig. 1.16) is produced by oxidation of lipids and lipoproteins within the lysosomal system. It appears as orange-brown granular material in sections stained with hematoxylin and eosin, and is acid-fast (as demonstrated by the long Ziehl–Neelsen method) and autofluorescent under ultraviolet light. The granules are also sudanophilic and stain with PAS and Schmorl’s stain. Lipofuscin accumulates with aging in neurons and glia, particularly in:

The lipofuscin accumulation is increased in some neurodegenerative disorders such as Alzheimer disease and motor neuron disease.

Granulovacuolar degeneration. This term describes the accumulation of vacuoles containing small round dense bodies (granulovacuoles) (Fig. 1.17). The dense bodies are ubiquitinated and react with antibodies to some epitopes of the microtubule-associated tau protein. The immunohistochemical data have been interpreted as suggesting that dense bodies are derived from partial degradation of tau protein within lysosomes. Although anti-phosphoTDP43 antibody is sensitive for detecting granulovacuolar degeneration, TDP43 proteinopathies are not associated with an increase in granulovacuoles. Granulovacuolar degeneration is seen in normal aging after the sixth decade, predominantly in the hippocampal formation. Neurons in the CA1 field are most severely affected and, in descending order of severity, those in the prosubiculum, CA2, CA3, and CA4 fields. The density of hippocampal neurons showing granulovacuolar degeneration is increased in patients with Alzheimer disease and Pick’s disease, in whom granulovacuolar degeneration may also occur in neurons in the subcortical nuclei.

Storage products in neurometabolic diseases. The accumulation of material within the acid vesicle system is a feature of many neurometabolic diseases including the lysosomal storage disorders, as well as certain other metabolic disorders caused by non-lysosomal enzyme defects. These disorders are considered in Chapter 23.

STRUCTURAL ABNORMALITIES OF AXONS

AXONAL SPHEROIDS AND DYSTROPHIC

AXONAL SWELLINGS

Spheroids are axonal swellings. They are composed of neurofilaments, organelles, and other material that is normally conveyed along the axon by anterograde transport systems, but accumulates focally when these are impaired (Fig. 1.18a,b). Spheroids are a feature of axonal damage by diverse extrinsic insults, especially trauma (see Chapter 11) and infarcts. There may be numerous axonal spheroids around the edge of an infarct.

The term ‘torpedo’ is applied to Purkinje cell axonal swellings, which are a feature of a wide range of metabolic and degenerative cerebellar diseases. These swellings appear as fusiform eosinophilic structures in the cerebellar granule cell layer (Fig. 1.18c,d). They are well demonstrated by silver impregnation (see chapter 29).

The axonal swellings that develop when axonal transport is disrupted by neuronal metabolic dysfunction are usually termed dystrophic (Fig. 1.18e). These occur in certain nutritional deficiencies (particularly vitamin E deficiency, see Chapter 21) and inherited metabolic diseases (e.g. Niemann–Pick disease type C). Dystrophic axonal swellings are the principal pathologic abnormality seen in a group of conditions termed the neuroaxonal dystrophies (see Chapter 33).

The term ‘dystrophic neurite’ is also used to describe neuronal processes within the gray matter that are distended by tau protein or other abnormal ubiquitinated material. These occur in several neurodegenerative diseases (Table 1.5).

Table 1.5

Dystrophic axons in aging and neurodegenerative diseases

Condition Dystrophic processes
Normal aging Neuronal processes accumulate dot-like ubiquitin- immunoreactive material (see Fig. 1.24)
Alzheimer disease The swollen neuronal processes around amyloid plaques are termed dystrophic neurites. Many contain ubiquitinated proteins, with or without accumulation of tau protein (Chapter 31)
Lewy body disease Abnormal neurites in affected brain regions can be detected by α-synuclein, ubiquitin or p62 immunohistochemistry (Chapter 28)
Huntington disease Abnormal neurites in the cerebral cortex can be detected by ubiquitin or p62 immunohistochemistry (Chapter 30)
Frontal lobe dementia Abnormal neurites in the cerebral cortex can be detected by TDP-43, ubiquitin or p62 immunohistochemistry (Chapter 31)

Dystrophic axons that react strongly with antibodies to ubiquitin and p62 are a feature of aging in the CNS, especially in the gracile and cuneate nuclei, the substantia nigra, the globus pallidus, and the anterior horns of the spinal cord.

In brains from people over 60 years of age, antibodies to ubiquitin label smaller dot-like structures in the neuropil of the cerebral cortex and in the white matter. These correspond to membrane-bound dense bodies in dystrophic neurites and foci of granular degeneration in myelin sheaths (Fig. 1.19).

PATHOLOGIC REACTIONS OF ASTROCYTES

Astrocytes are vital support cells of the nervous system. They can be demonstrated by a range of tinctorial stains and immunohistochemical techniques (Fig. 1.20) and undergo a range of structural changes in reaction to CNS disease.

FIBRILLARY GLIOSIS

With time, reactive astrocytes proliferate and insinuate long cytoplasmic processes into the adjacent brain parenchyma. These processes contain bundles of glial intermediate filaments, which appear as fibrils in appropriately stained preparations; hence the term fibrillary gliosis. The abundance of glial intermediate filaments is readily demonstrated by immunostaining for GFAP. Two patterns of fibrillary gliosis are recognized:

ROSENTHAL FIBERS

Rosenthal fibers are inclusions that develop in astrocytes in chronic reactive and neoplastic proliferations. They are brightly eosinophilic structures of variable size and shape (Fig. 1.24a,b). On electron microscopy they contain admixed amorphous granular material and 10 nm diameter filaments (Fig. 1.24c). Immunohistochemistry reveals GFAP, αB-crystallin, 27 kD heat-shock protein, and ubiquitin at the periphery of the Rosenthal fibers (Fig. 1.24d–f), while the central hyaline region is generally unlabeled.

Rosenthal fibers are seen in longstanding reactive gliosis, especially when it occurs in the spinal cord, cerebellum, or hypothalamus. They are also a feature of pilocytic astrocytomas. Rosenthal fibers are abundant in Alexander’s disease and in giant axonal neuropathy.

TAU-IMMUNOREACTIVE GLIA

Tau protein has long been known to be the main constituent of neurofibrillary tangles, which are neuronal inclusions in Alzheimer disease and several other disorders (see Chapters 28, 29, and 31), but the recognition that glial cells can accumulate tau protein is a relatively recent finding. Several different types of tau-immunoreactive inclusions have been described (Fig. 1.26, Table 1.6). See also Pathologic reactions of oligodendroglia, p.16.

Table 1.6

Tau-reactive glial abnormalities

Type Association(s) Immunoreactivity
Glial fibrillary tangles PSP, CBD, Pick’s disease Tau
Tufted astrocytes PSP, Pick’s disease Tau
Thorn-shaped astrocytes Several degenerative diseases Tau
Interfascicular threads PSP and CBD white matter (oligodendroglial inclusions) Tau
Coils and threads PSP, CBD, FTDP-17 Tau
Astrocytic plaques CBD Tau
Glial cytoplasmic inclusions Multiple system atrophy, CBD α-synuclein, tau, ubiquitin

PSP, progressive supranuclear palsy; CBD, corticobasal degeneration.

CORPORA AMYLACEA

Corpora amylacea are spherical inclusions, predominantly in astrocyte processes (Fig. 1.27a,b), although they occasionally occur within axons. They range from 10 μm to 50 μm in diameter, consist largely of polyglucosans, and stain with hematoxylin, PAS, and methyl violet. Minor constituents include ubiquitin, heat-shock proteins, tau protein, complement proteins, and some oligodendrocyte proteins (i.e. myelin basic protein, proteolipid protein, galactocerebroside, and myelin oligodendrocyte glycoprotein). Ultrastructurally, corpora amylacea consist of densely packed 6–7 nm filaments that may be admixed with amorphous granular material and are not membrane bound.

Corpora amylacea increase in number with normal aging, particularly in subpial (Fig. 1.27c) and subependymal regions, around subcortical blood vessels, and in the spinal white matter. Their increase in number is greater in conditions where there has been atrophy and gliosis, including Alzheimer disease and other neurodegenerative disorders. Transglutaminase 1-mediated cross-linking and polymerization of cytoskeletal or cytoskeletal-associated proteins has been postulated as a mechanism of corpora amylacea formation.

The functions of corpora amylacea, if any, are not known. Suggestions include a role in the accumulation of inorganic materials from the blood and cerebrospinal fluid or in shielding immunogenic products of neuronal and oligodendroglial degeneration from lymphocytic recognition and autoimmune activation.

NUCLEAR CHANGES IN ASTROCYTES

Alzheimer type II astrocytes are seen in cortical and subcortical gray matter regions in liver failure. They have an enlarged vesicular nucleus with marginated chromatin, scanty cytoplasm, and little or no demonstrable GFAP (Figs 1.281.32) (see also Chapter 22).

PATHOLOGIC REACTIONS OF OLIGODENDROGLIA

Oligodendroglia occur perineuronally, where they may have a neuroprotective function, and in the white matter, where they form myelin sheaths. In size and shape the nucleus of an oligodendrocyte resembles that of a lymphocyte. The scanty perinuclear cytoplasm gives rise to multiple fine processes; in the white matter each of these has a terminal, sheet-like expansion that enwraps an axon in multiple compacted layers of myelin to form an internode. Adjacent internodes along the axon are separated by highly specialized regions known as nodes of Ranvier. Oligodendrocytes show a range of responses to injury that vary according to the nature of the insult, and whether it is directed primarily at the cell body or the myelin sheath.

IMMUNOHISTOCHEMICAL FEATURES

During their development, oligodendrocyte progenitors pass through a series of stages, each with a distinct antigenic profile. Oligodendrocyte progenitors that express platelet-derived growth factor-α receptor, the chondroitin-sulfate proteoglycan NG2, and other progenitor-specific markers, persist in white matter into adulthood, although their immunohistochemical demonstration is technically difficult and requires well-preserved frozen tissue. In normal white matter they are greatly outnumbered by mature oligodendrocytes. Mature oligodendrocytes are usually identified by the size, shape, and arrangement of their nuclei. In gray matter these are adjacent to neurons; in white matter they tend to form short rows, between fascicles of myelinated axons. In paraffin or frozen sections, myelin sheaths are readily demonstrable with Luxol fast blue or solochrome cyanin. Mature myelinating oligodendrocytes can be immunostained with antibodies to myelin oligodendrocyte glycoprotein or myelin basic protein, but these antigens may not be demonstrable after prolonged fixation in formalin.

DEMYELINATION AND REMYELINATION

Demyelination, or loss of normal myelin with relative preservation of axons, may result from selective destruction of the myelin sheath, or may be secondary to damage to the oligodendrocyte cell body. Demyelination is often immunologically mediated, as in multiple sclerosis (see Chapter 19) and acute disseminated encephalomyelitis (see Chapter 20), but can also be caused by toxic and metabolic insults (see Chapters 22 and 25), viral infection (see Chapter 13), compression (see Chapter 20), and ischemia (see Chapter 9). Areas of demyelination show loss of staining with Luxol fast blue, or solochrome cyanin (Fig. 1.33). Electron microscopy demonstrates the absence of myelin sheaths. Remyelinated nerve fibers have myelin sheaths that are abnormally thin in relation to the caliber of the axon (Fig. 1.33). Groups of remyelinated fibers are visible histologically as discrete areas of white matter in which staining of myelin is present but reduced (Fig. 1.33).

INTRAMYELINIC VACUOLATION

Several disorders of the CNS cause a distinctive pattern of edema in which the initial accumulation of fluid is in ‘vacuoles’ formed by separation of the layers of the myelin sheath along intraperiod lines. On light microscopy, this intramyelinic vacuolation gives the white matter a spongy appearance (Fig. 1.34). The causes include some mitochondrial encephalopathies (particularly Kearns–Sayre syndrome; see Chapter 24), Canavan’s disease and several disorders of amino acid metabolism (see Chapter 5), vitamin B12 deficiency (see Chapter 21), various toxins (see Chapter 25), and retroviral infections – vacuolar myelopathy due to HIV, and myelopathy due to HTLV-1 (see Chapter 13).

INCLUSIONS

Oligodendrocytes accumulate cytoplasmic aggregates of filamentous or microtubular material in several neurodegenerative diseases. Inclusions that consist largely of tau protein are a feature of progressive supranuclear palsy, corticobasal degeneration, and frontotemporal lobar degeneration linked to chromosome 17 (FTDP-17). In these diseases (discussed in detail in Chapters 28 and 31), tau inclusions occur in the perinuclear oligodendrocyte cytoplasm where they often partially encircle the nucleus and are called ‘coiled bodies’ (Fig. 1.35). In progressive supranuclear palsy, delicate strands of aggregated tau also occur in the in the inner and outer loops of the myelin sheath, forming inclusions know as ‘glial threads’ or ‘interfascicular threads’. In multiple system atrophy (see Chapter 28), oligodendrocytes form ‘glial cytoplasmic inclusions’ (GCIs) – curved, filamentous, flame- or sickle-shaped inclusions that often partly encircle the nucleus (Fig. 1.35). They are readily demonstrable by Gallyas silver impregnation, and immunohistochemically with antibodies to α-synuclein (Fig. 1.35). They can also be labeled with antibodies to ubiquitin, and some antibodies to tau. Electron microscopy shows GCIs to consist of microtubular structures with a coating of granular material.

PATHOLOGIC REACTIONS OF EPENDYMA

Ependymal cells line ventricular cavities and the central canal of the spinal cord, have limited proliferative potential, and only a small repertoire of responses to injury.

RESPONSES TO INJURY

Ependymal cells are usually columnar with basal nuclei and prominent cilia (Fig. 1.36). A distinct ependymal lining is present around the central canal of the spinal cord in utero and during infancy, but with age this cavity is largely obliterated, leaving discontinuous stretches of canal and disorganized clusters of ependymal cells in later life (Fig. 1.37). Enlargement of an intact central canal (hydromyelia) is usually an incidental finding at necropsy (Fig. 1.37). It has been speculated that in some patients with hydromyelia, progressive enlargement of the central canal may lead to injury and sloughing of ependyma, with progressive enlargement, and transformation into syringomyelia (see Chapter 3).

image

image

image

image

1.37 Central canal of the spinal cord.
(a) In transverse sections through the cord in infants and children this appears as a circular, oval or ‘forked’ cavity surrounded by ciliated columnar ependymal cells similar to those illustrated in Fig. 1.32. (b) With age, the central lumen of the canal tends to disappear, leaving a variably disorganized meshwork of ependymal cells. (c) and (d) enlargement of central canal. In (d) there is focal loss of ependyma (arrows), possibly representing an early stage of syringomyelia. Note the prominent astrocytosis underlying the regions of ependymal loss.

The following histopathologic responses may occur:

ATROPHY

There is loss of cytoplasm in ependymal cells, which become flattened. Nuclei lose their basal position and encroach upon the rest of the cytoplasm in affected ependymal cells (Fig. 1.38). Atrophy usually occurs in association with hydrocephalus or cerebral atrophy (e.g. in encephalopathies of childhood, age-related dementias).

image

image

1.38 Atrophy of ependyma.
(a) Contrast appearance with that of normal ependyma, shown in Fig. 1.36. (b) Focal discontinuities of ependyma, possibly a sequel of severe atrophy.

SUBVENTRICULAR GLIOSIS (GRANULAR EPENDYMITIS, EPENDYMAL GRANULATIONS)

This probably occurs within 1–2 weeks of ependymal tearing or other injury. Proliferation of astrocytes occurs in the subventricular region, and astrocytic processes produce a dense meshwork that extends along the denuded ventricular lining and may form nodular protrusions into the ventricular cavity (Fig. 1.39). The formation of these subventricular glial nodules is sometimes termed ‘granular ependymitis’, although it is not often part of an inflammatory process. When subventricular gliosis is associated with ventricular hemorrhage, hemosiderin-laden macrophages are present.

INCLUSIONS IN EPENDYMAL CELLS AND CHOROID PLEXUS EPITHELIUM

BIONDI BODIES

These are intracellular accumulations of amyloid fibrils in ependymal cells and choroid plexus epithelium. The number of Biondi bodies increases with age, and they are consistently present in large numbers in the elderly. In choroid plexus epithelium the fibrils may be arranged in wispy strands or large cytoplasmic rings, which are also known as Biondi rings (Fig. 1.40). In ependymal cells the fibrils appear as irregular strands rather than rings. The fibrils consist of tightly packed bundles of straight 10 nm filaments, which stain with thioflavin S and less intensely with Sirius red or Congo red. They have been reported to react with antibody to Aβ-amyloid.

Biondi bodies persist even after the autolysis of other tissues and their density in homogenates of choroid plexus has been used to provide a rapid indication of the age of an unidentified corpse.

PATHOLOGIC REACTIONS OF MICROGLIA

MICROGLIAL ACTIVATION AND ROD CELL FORMATION

Microglia are cells of monocyte lineage and are inconspicuous in the normal brain. They can be demonstrated by silver impregnation (Fig. 1.41a), but this has been largely superseded by immunohistochemical and lectin-binding techniques. The antibodies and lectins that label microglia are mostly those that react with monocyte–macrophage markers (Fig. 1.41b). Microglia in normal brain have been subdivided into:

Microglial activation occurs in many reactive, particularly inflammatory, conditions of the CNS, especially encephalitides, and involves:

In sections stained with hematoxylin and eosin, infiltrating monocytes or microglia can be recognized by their rod-shaped nucleus (Fig. 1.41d). These ‘rod cells’ are a prominent finding in chronic infections such as general paresis (see Chapter 16) and chronic viral encephalitides (see Chapter 13).

In regions of tissue damage hematogenous monocytes infiltrate the CNS and phagocytose dead cells and necrotic debris. The accumulation of lipid material by phagocytic cells gives their cytoplasm a foamy appearance in paraffin-embedded material and they are therefore often described as ‘foam cells’ or ‘foamy macrophages’ (Fig. 1.42).

MINERALIZATION IN THE BRAIN

Mineralization of the brain is common, especially in the basal ganglia, which show incidental vascular mineralization in 1–2% of the population as a whole and a much higher proportion of the elderly.

Deposits are most common and extensive in the globus pallidus, putamen, caudate nucleus, internal capsule, dentate nucleus, the lateral part of the thalamus, and the pineal gland.

Small mineral deposits can be found in most parts of the brain. They are deeply basophilic, and stain for calcium and, variably, for iron. Early mineralization takes the form of rows of small calcospherites lying along capillaries (Fig. 1.43a). These small deposits may enlarge to form large perivascular concretions (Fig. 1.43b). Larger deposits also occur within the media of small and medium-sized arteries and veins (Fig. 1.43c). Large foci of mineralization are presumed to result from coalescence of smaller deposits (Fig. 1.43d).

Parenchymal calcospherites can be seen in a small proportion of pineal glands during the first decade, developing much earlier than mineralization elsewhere in the brain. The frequency of pineal mineralization rises steeply during the second decade, but remains fairly constant thereafter, although the deposits may undergo remodeling.

Brain mineralization is a feature of several diseases including disorders of calcium metabolism, some neurodegenerative disorders, mitochondrial encephalopathies, and viral and parasitic infections. The neuropathologic findings in these conditions are described in the relevant chapters.

PATHOLOGIC REACTIONS OF BLOOD VESSELS

The central nervous system vasculature may demonstrate a broad range of pathologic changes. These are discussed in greater detail in Chapters 710. Atherosclerosis, thromboembolic disease, vascular malformations, aneurysms, vasculitides, infections, and other vasculopathies may involve the blood vessels of the brain. Highlighted here are some entities that are distinctive or that can cause diagnostic confusion. In cerebral amyloid angiopathy (Chapter 31), the amyloid is rarely that seen in systemic amyloidoses (Fig. 1.44a–c). Amyloid-β (Aβ), the same protein as that in the plaques of Alzheimer disease, is the most common vascular deposit in elderly patients. The involved blood vessels are typically leptomeningeal or cortical; not surprisingly therefore, rupture of Aβ-laden blood vessels usually results in superficial lobar hemorrhage. Hypertension can result in arteriosclerosis, including arteriolosclerosis (Chapter 31). Hypertensive hemorrhages often involve deep gray matter and may extend into the ventricles. With routine stains, the collagen of arteriolosclerosis can be difficult to distinguish from amyloid angiopathy but a combination of amyloid and collagen stains can be helpful (Fig. 1.44a–d). Amyloid deposition and atherosclerosis may co-exist. Fibrinoid necrosis of the blood vessel wall typically occurs in the context of radiation necrosis or vasculitis (Fig. 1.44e) and should not be confused with amyloid angiopathy. The patient’s presentation and other pathologic features usually obviate the necessity for special stains. In addition to thromboemboli, intravascular iatrogenic foreign material can be seen. Meningiomas and vascular malformations are often embolized preoperatively with polyvinyl alcohol or acrylic particles. The embolic material leaves intravascular areas devoid of red blood or white blood cells and fibrin. Intermediate to large-sized blood vessels within the tumor, vascular malformation, or dura are most likely to be affected (Fig. 1.44f). Depending on the type of embolic material, the embolic material may appear amorphous, pigmented material, or as empty spaces if the material is removed during processing. Hydrophilic polymers stripped from the coatings of interventional devices during endovascular procedures can occlude microvessels in the brain parenchyma (Fig. 1.44g) resulting in microinfarcts. The polymers are often gray to basophilic and may be serpentine or needle-shaped. The polymers are not polarizable and may elicit little inflammatory response.

REFERENCES

Pathologic reactions of neurons

Beach, T.G., Walker, D.G., Sue, L.I., et al. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers. J Neuropathol Exp Neurol.. 2004;63:329–337.

Dickson, D.W. α-synuclein and the Lewy body disorders. Curr Opin Neurol.. 2001;14:423–432.

Goedert, M., Spillantini, M.G., Davies, S.W. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol.. 1998;8:619–632.

Hirano, A. Hirano bodies and related neuronal inclusions. Neuropathol Appl Neurobiol.. 1994;20:3–11.

Mackenzie, I.R. The neuropathology of FTD associated With ALS. Alzheimer Dis Assoc Disord.. 2007;21:S44–S49.

Mackenzie, I.R., Rademakers, R., Neumann, M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol.. 2010;9:995–1007.

Martinez-Saez, E., Gelpi, E., Rey, M., et al. Hirano body-rich subtypes of Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol.. 2011. [doi:org/10.1111/j.1365–2990.2011.01208.x].

Mizuno, Y., Fujita, Y., Takatama, M., et al. Peripherin partially localizes in Bunina bodies in amyotrophic lateral sclerosis. J Neurol Sci.. 2011;302:14–18.

Okamoto, K., Mizuno, Y., Fujita, Y. Bunina bodies in amyotrophic lateral sclerosis. Neuropathology.. 2008;28:109–115.

Thal, D.R., Del Tredici, K., Ludolph, A.C., et al. Stages of granulovacuolar degeneration: their relation to Alzheimer’s disease and chronic stress response. Acta Neuropathol.. 2011;122:577–589.

Turnbull, J., Wang, P., Girard, J.M., et al. Glycogen hyperphosphorylation underlies Lafora body formation. Ann Neurol.. 2010;68:925–933.

Pathologic reactions of astrocytes and oligodendrocytes

Ahmed, Z., Doherty, K.M., Silveira-Moriyama, L., et al. Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies. Acta Neuropathol.. 2011;122:415–428.

Bradl, M., Lassmann, H. Oligodendrocytes: biology and pathology. Acta Neuropathol.. 2010;119:37–53.

Fellner, L., Jellinger, K.A., Wenning, G.K., et al. Glial dysfunction in the pathogenesis of a-synucleinopathies: emerging concepts. Acta Neuropathol.. 2011;121:675–693.

Iwaki, T., Iwaki, A., Tateishi, J., et al. αB-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Pathol.. 1993;143:487–495.

Komori, T. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick’s disease. Brain Pathol.. 1999;9:663–679.

Love, S. Demyelinating diseases. J Clin Pathol.. 2006;59:1151–1159.

Matsusaka, H., Ikeda, K., Akiyama, H., et al. Astrocytic pathology in progressive supranuclear palsy: significance for neuropathological diagnosis. Acta Neuropathol.. 1998;96:248–252.

Quinlan, R.A., Brenner, M., Goldman, J.E., et al. GFAP and its role in Alexander disease. Exp Cell Res.. 2007;313:2077–2087.

Sidoryk-Wegrzynowicz, M., Wegrzynowicz, M., Lee, E., et al. Role of astrocytes in brain function and disease. Toxicol Pathol.. 2011;39:115–123.

Takahashi, M., Weidenheim, K.M., Dickson, D.W., et al. Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy. J Neuropathol Exp Neurol.. 2002;61:33–45.

Takeda, A., Arai, N., Komori, T., et al. Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett.. 1997;234:63–66.

Verkhratsky, A., Parpura, V. Recent advances in (patho)physiology of astroglia. Acta Pharmacol Sin.. 2010;31:1044–1054.

Wakabayashi, K., Takahashi, H. Cellular pathology in multiple system atrophy. Neuropathology.. 2006;26:338–345.

Wilhelmus, M.M., Verhaar, R., Bol, J.G., et al. Novel role of transglutaminase 1 in corpora amylacea formation? Neurobiol Aging.. 2011;32:845–856.

Pathologic reactions of ependyma

Biondi, G. Zur Histopathologie des menschlichen Plexus Chorioideus und des Ependyms. Arch Psychiatr Nervenkr.. 1934;101:666–728.

Bruni, J.E. Ependymal development, proliferation, and functions: a review. Microsc Res Tech.. 1998;41:2–13.

Eriksson, L., Westermark, P. Characterization of intracellular amyloid fibrils in the human choroid plexus epithelial cells. Acta Neuropathol.. 1990;80:597–603.

Sarnat, H.B. Regional differentiation of the human fetal ependyma: immunocytochemical markers. J Neuropathol Exp Neurol.. 1992;51:58–75.

Sarnat, H.B. Ependymal reactions to injury. A review. J Neuropathol Exp Neurol.. 1995;54:1–15.

Vinters, H.V. Neuropathology of syringomyelia. In: Batzdorf U., ed. Syringomyelia: current concepts in diagnosis and treatment. Baltimore: Williams & Wilkins; 1991:35–58.

Wolburg, H., Paulus, W. Choroid plexus: biology and pathology. Acta Neuropathol.. 2010;119:75–88.